
Keywords: CRS; cytoreductive surgery; HA; hyaluronic acid; IP; intraperitoneal; IPEC; intraperitoneal chemotherapy; HIPEC; hyperthermic intraperitoneal chemoperfusion; IFP; interstitial fluid pressure; MDR; multi drug resistance; MPs; microparticles; NPs; nanoparti